Compare PTCT & POST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | POST |
|---|---|---|
| Founded | 1998 | 1895 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.0B |
| IPO Year | 2006 | 2011 |
| Metric | PTCT | POST |
|---|---|---|
| Price | $71.41 | $84.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 7 |
| Target Price | $80.65 | ★ $124.50 |
| AVG Volume (30 Days) | 794.0K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 264.48 | N/A |
| EPS | 0.90 | ★ 4.59 |
| Revenue | $264,734,000.00 | ★ $8,158,100,000.00 |
| Revenue This Year | N/A | $4.93 |
| Revenue Next Year | $17.70 | $0.47 |
| P/E Ratio | $79.77 | ★ $18.37 |
| Revenue Growth | ★ 36.19 | 2.97 |
| 52 Week Low | $57.08 | $75.40 |
| 52 Week High | $90.87 | $116.35 |
| Indicator | PTCT | POST |
|---|---|---|
| Relative Strength Index (RSI) | 45.98 | 50.42 |
| Support Level | $67.57 | $76.27 |
| Resistance Level | $73.86 | $93.96 |
| Average True Range (ATR) | 2.00 | 2.44 |
| MACD | 0.17 | 0.73 |
| Stochastic Oscillator | 54.41 | 73.35 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Post Holdings Inc. is a consumer packaged goods holding company with products sold through grocery, club, and drug stores, mass merchandisers, foodservice, food ingredient, and eCommerce. It operates through four reportable segments: Post Consumer Brands, focused on North American ready-to-eat cereal and granola, pet food, and nut butters; Weetabix, focused on U.K. ready-to-eat cereal, muesli, and protein-based shakes; Foodservice, focused on egg and potato products; and Refrigerated Retail, focused on side dish, egg, cheese, and sausage products. Products are sold across channels, including retailers, wholesalers, convenience stores, pet supply retailers, drug store customers, military and national restaurant chains, with revenues largely generated in the U.S.